Galectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis

Vista sencilla de ítem
dc.contributor.authorPardo, Evelyn
dc.contributor.authorCárcamo, Claudia
dc.contributor.authorMartín, Reinaldo Uribe-San
dc.contributor.authorCiampi, Ethel
dc.contributor.authorSegovia-Miranda, Fabián
dc.contributor.authorCurkovic-Peña, Cristobal
dc.contributor.authorMontecino, Fabián
dc.contributor.authorHolmes, Christopher
dc.contributor.authorTichauer, Juan Enrique
dc.contributor.authorAcuña, Eric
dc.contributor.authorOsorio-Barrios, Francisco
dc.contributor.authorCastro, Marjorie
dc.date.accessioned2024-04-10T18:58:09Z
dc.date.available2024-04-10T18:58:09Z
dc.date.issued2017-06
dc.descriptionINDEXACIÓN: SCOPUS.
dc.description.abstractGalectin-8 (Gal-8) is a member of a glycan-binding protein family that regulates the immune system, among other functions, and is a target of antibodies in autoimmune disorders. However, its role in multiple sclerosis (MS), an autoimmune inflammatory disease of the central nervous system (CNS), remains unknown. We study the consequences of Gal-8 silencing on lymphocyte subpopulations and the development of experimental autoimmune encephalitis (EAE), to then assess the presence and clinical meaning of anti-Gal-8 antibodies in MS patients. Lgals8/Lac-Z knock-in mice lacking Gal-8 expression have higher polarization toward Th17 cells accompanied with decreased CCR6+ and higher CXCR3+ regulatory T cells (Tregs) frequency. These conditions result in exacerbated MOG35-55 peptide-induced EAE. Gal-8 eliminates activated Th17 but not Th1 cells by apoptosis and ameliorates EAE in C57BL/6 wild-Type mice. β-gal histochemistry reflecting the activity of the Gal-8 promoter revealed Gal-8 expression in a wide range of CNS regions, including high expression in the choroid-plexus. Accordingly, we detected Gal-8 in human cerebrospinal fluid, suggesting a role in the CNS immune-surveillance circuit. In addition, we show that MS patients generate function-blocking anti-Gal-8 antibodies with pathogenic potential. Such antibodies block cell adhesion and Gal-8-induced Th17 apoptosis. Furthermore, circulating anti-Gal-8 antibodies associate with relapsing-remitting MS (RRMS), and not with progressive MS phenotypes, predicting clinical disability at diagnosis within the first year of follow-up. Our results reveal that Gal-8 has an immunosuppressive protective role against autoimmune CNS inflammation, modulating the balance of Th17 and Th1 polarization and their respective Tregs. Such a role can be counteracted during RRMS by anti-Gal-8 antibodies, worsening disease prognosis. Even though anti-Gal-8 antibodies are not specific for MS, our results suggest that they could be a potential early severity biomarker in RRMS. © 2017 Pardo et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.identifier.citationPLoS ONE, Volume 12, Issue 6, June 2017, Article number e0177472
dc.identifier.doi10.1371/journal.pone.0177472
dc.identifier.issn1932-6203
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/55858
dc.language.isoen
dc.publisherPublic Library of Science
dc.rights.licenseCC BY 4.0 DEED Atribución 4.0 Internacional
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/deed.es
dc.subjectAnimals
dc.subjectApoptosis
dc.subjectAutoantibodies
dc.subjectBrain
dc.subjectCell Adhesion
dc.subjectEncephalomyelitis, Autoimmune, Experimental
dc.subjectFemale
dc.subjectGalectins
dc.subjectGene Silencing
dc.subjectHumans; Mice
dc.subjectMice, Inbred C57BL
dc.subjectMice, Transgenic
dc.subjectMultiple Sclerosis
dc.subjectPrognosis
dc.subjectT-Lymphocytes, Regulatory
dc.subjectTh17 Cells
dc.titleGalectin-8 as an immunosuppressor in experimental autoimmune encephalomyelitis and a target of human early prognostic antibodies in multiple sclerosis
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
Galectin8-as-an-immunosuppressor-in-experimental-autoimmune-encephalomyelitis-and-a-target-of-human-early-prognostic-antibodies-in-multiple-sclerosisPLoS-ONE.pdf
Tamaño:
8.69 MB
Formato:
Adobe Portable Document Format
Descripción:
TEXTO COMPLETO EN INGLÉS.
Descargar
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción:
Descargar
Colecciones
Fac.CV - Artículos de Revista